Spectral AIMDAI -0.58%6 FCF Yield % is -22.18 as of Jul. 11, 2026. GuruFocus rates MDAI with a GF Score™ of 6/100 and a GF Value™ of $0.91 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Spectral AI ranks worse than 83.63% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Spectral AI FCF Yield % Related Terms
Spectral AI FCF Yield % Historical Data
* Premium members only.
The historical data trend for Spectral AI's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Spectral AI's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Spectral AI's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI (MDAI) has a FCF Yield % of -22.18 as of Jul. 11, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Spectral AI and its competitors. According to the industry distribution chart, Spectral AI ranks #715 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 83.6%.
Is Spectral AI's FCF Yield % too high?
Spectral AI's current FCF Yield % is -22.18. Based on the distribution chart, Spectral AI ranks #715 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Spectral AI has a GF Score™ of 6/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral AI's FCF Yield % compare to LUNG and QTI?
According to the Medical Devices & Instruments industry distribution chart, Spectral AI ranks #715 out of 855 companies for FCF Yield %. This places Spectral AI in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Spectral AI and its competitors. Spectral AI's current FCF Yield % is -22.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral AI stock overvalued right now?
Based on GuruFocus' analysis, Spectral AI (MDAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.91, compared to a current price of $1.72 — trading 89% above its estimated fair value. The current FCF Yield % is -22.18. Spectral AI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Spectral AI (MDAI), the current FCF Yield % is -22.18 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spectral AI (MDAI) Overvalued in 2026?
Based on GuruFocus' analysis, Spectral AI stock appears to be overvalued.
The current stock price of $1.72 is trading 89% above its estimated GF Value™ of $0.91.
GuruFocus considers Spectral AI to be Significantly Overvalued.
Key valuation signals for MDAI:
FCF Yield %: -22.18
GF Value™: $0.91 vs. price of $1.72 (89% above fair value)
No single metric tells the full story. See the MDAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
6GF Score
Get the complete analysis for MDAI
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDAI has been successfully added to your 
